Antimicrobial Agents and Chemotherapy

It’s vital to optimize use of antimicrobials Optimize antimicrobial use to confirm effectiveness whereas minimizing resistance development in common community-acquired infections Identify management ways to stop, or minimize clinically important drug interactions with common antimicrobials. Safety and effectiveness of intravenous iron in patients with chemotherapyelicited anaemia receiving darbepoetin alpha Effects of endogenous (IV) iron supplementation on responses to every-three-week (Q3W) darbepoetin alpha (DA) by baseline haemoglobin in patients (pts.) with chemotherapy-induced anemia (CIA)1 A phase III clinical trial randomised controlled study comparison iron saccharose intravenously (IV) to no iron treatment of anemia in cancer patients undergoing therapy and glycoprotein stimulating agent (ESA) therapy Improvement in quality of life precedes increase in haemoglobin levels upon treatment with intravenous iron and epoetin alpha.

    Related Conference of Antimicrobial Agents and Chemotherapy

    June 09-10, 2020

    10th European Epidemiology and Public Health Congress

    Istanbul, Turkey
    July 22-23, 2020

    10th World Congress on Rare Diseases and Orphan Drugs

    Barcelona, Spain
    August 19-20, 2020

    European Summit on HIV, STD and STIs

    Milan, Italy
    September 28-29, 2020

    13th Global Infections Conference

    Singapore
    October 5-6, 2020

    12th Euro-Global Conference on Infectious Diseases

    Vienna, Austria
    February 15-16, 2021

    8th International Congress on Infectious Diseases

    London, UK

    Antimicrobial Agents and Chemotherapy Conference Speakers

    Recommended Sessions

    Related Journals

    Are you interested in